To evaluate SHR8008 capsules for the treatment of acute vulvovaginal candidiasis VVC Randomized, double-blind, double-simulation, fluconazole parallel control, efficacy and safety, Multi-center Phase III clinical study
| Title | To evaluate SHR8008 capsules for the treatment of acute vulvovaginal candidiasis VVC Randomized, double-blind, double-simulation, fluconazole parallel control, efficacy and safety, Multi-center Phase III clinical study |
|---|---|
| Description | Oteseconazole Versus Fluconazole for the Treatment of Vulvovaginal Candidiasis: A Multicenter, Randomized, and Double-Blinded Phase 3 Study |
| Organism | Homo sapiens |
| Data Type | Clinical Research data |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA011638 |
| Release Date | 2022-12-31 |
| Submitter | binbin liu (binbin.liu@hengrui.com) |
| Organization | Jiangsu Hengrui Pharmaceutical Co., Ltd |
| Submission Date | 2022-10-25 |
HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download Times | Download |
|---|---|---|---|---|---|---|---|
| OMIX002208-02 | Data required for the paper | 1 | Clinical Research data | 524.6 KB | zip | 0 | Controlled |